TrialNeuro-oncology2025

Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study.

Hirokazu Takami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.